σεμαγλουτίδη
An important development for the treatment of severe fatty liver disease was recently announced by the British Medicines Regulatory Authority (MHRA), which granted conditional marketing authorization to semaglutide (semaglutide – Wegovy) for the treatment of adults with metabolically related st…
Peak volume
500+
First seen
2026-08-09
Last seen
2026-08-09
Days trending
1 / 1
Countries
1